Lates News

date
04/02/2026
Novo Nordisk ADR fell 12% as its previously released 2026 sales outlook fell short of expectations. The decline in Novo Nordisk's stock price dragged down shares of weight-loss drug concept stocks, with Sodexo Biotechnology down 4.7%, HIMS down 3.4%, Pfizer down 3%, Eli Lilly down 2.7%, and Furtai Pharmaceutical down 1.8%.
Latest
See all latestmore